title: [Reducing anxiety without deterioration of cognitive functions].
abstract: The purpose of the study--demonstrate the ability to reduce anxiety without having a negative impact on concentration and memory. In patients with irritable bowel syndrome studied anxiety, cognitive dysfunction, and memory. Patients received a standard basic therapy or standard treatment with psychotropic medication. Inclusion in the healing process valemidin significantly reduced anxiety in patients without a negative impact on cognitive function. IBS patients receiving basic therapy addition, valemidin, compared with the group of patients receiving only the basic therapy significantly decreased and cognitive dysfunction.
authors.forename: T V
authors.initials: TV
authors.lastname: Reshetova
authors.forename: T N
authors.initials: TN
authors.lastname: Zhigalova
authors.forename: A A
authors.initials: AA
authors.lastname: Gazieva
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy / Q000523:psychology*; D008297:Male; D008568:Memory / Q000187:drug effects*
chemical_list: D014151:Anti-Anxiety Agents